Capricor Therapeutics Inc
F:4LN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
Saipem SpA
F:SPE1
|
IT |
|
thyssenkrupp AG
F:TKA
|
DE |
|
A
|
Advanced Micro Devices Inc
MIL:1AMD
|
US |
|
D
|
Diageo PLC
BMV:DEON
|
UK |
|
C
|
Cencora Inc
XMUN:ABG
|
US |
|
V
|
Vector Group Ltd
DUS:VGR
|
US |
|
Stellantis NV
PAR:STLAP
|
NL |
|
M
|
Mondelez International Inc
F:KTF
|
US |
|
H
|
Harmony Gold Mining Company Ltd
SWB:HAM
|
ZA |
|
A
|
Anglo American Platinum Ltd
XMUN:RPHA
|
ZA |
|
C
|
Commerzbank AG
BMV:CBKN
|
DE |
|
N
|
Nippon Television Holdings Inc
TSE:9404
|
JP |
|
D
|
Diageo PLC
SWB:GUI
|
UK |
|
W
|
WSOL PCL
SET:WSOL
|
TH |
|
Firstcash Holdings Inc
F:FF60
|
US |
|
PKSHA Technology Inc
F:762
|
JP |
|
I
|
ITV PLC
XMUN:IJ7
|
UK |
|
Draegerwerk AG & Co KGaA
F:DRW8
|
DE |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
|
I
|
ImmunoGen Inc
F:IMU
|
US |
|
F
|
Ford Motor Co
XMUN:FMC1
|
US |
Wall St Price Targets
4LN2 Price Targets Summary
Capricor Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
4LN2 is 10.83 EUR with a low forecast of 7.53 EUR and a high forecast of 12.98 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LN2's stock price target?
Price Target
10.83
EUR
According to Wall Street analysts, the average 1-year price target for
4LN2 is 10.83 EUR with a low forecast of 7.53 EUR and a high forecast of 12.98 EUR.